Ibuprofen+ Paracetamol
This medicine should always be taken exactly as described in the patient leaflet or as advised by your doctor or pharmacist.
The medicine is called Ibuxal Plus. Ibuxal Plus contains two active substances (which make the medicine work). These are ibuprofen and paracetamol.
Ibuprofen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
The action of NSAIDs is to reduce pain, reduce swelling, and lower high body temperature.
Paracetamol is a pain reliever that, acting differently than ibuprofen, relieves pain and fever.
Ibuxal Plus is used for short-term treatment of mild to moderate pain associated with migraine, headache, back pain, menstrual pain, toothache, muscle pain, treatment of cold and flu symptoms, sore throat, and fever.
If after 3 days there is no improvement or you feel worse, you should contact your doctor.
Before taking Ibuxal Plus, you should discuss it with your doctor or pharmacist if you:
While taking Ibuxal Plus, you should immediately inform your doctor if:
Taking anti-inflammatory and pain relievers, such as ibuprofen, may be associated with a small increased risk of heart attack or stroke, especially when taken in high doses. Do not exceed the recommended dose and duration of treatment.
Before starting to take Ibuxal Plus, you should discuss it with your doctor or pharmacist if:
Infections
Ibuxal Plus may mask the symptoms of an infection, such as fever and pain. Therefore, Ibuxal Plus may delay the use of appropriate infection treatment and consequently lead to an increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you are taking this medicine while an infection is present, and the symptoms of the infection persist or worsen, you should immediately consult a doctor.
Skin reactions
Serious skin reactions have been reported with the use of Ibuxal Plus. If you experience any skin rash, changes in the mucous membranes, blisters, or other signs of an allergic reaction, you should stop taking this medicine immediately and seek medical attention, as these may be the first signs of a very serious skin reaction. See section 4.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Do not take Ibuxal Plus:
Ibuxal Plus may affect some other medicines or other medicines may affect its action, for example:
Some other medicines may also affect the action of Ibuxal Plus or their action may change under the influence of this medicine. You should always consult your doctor or pharmacist before taking Ibuxal Plus with other medicines.
To reduce the likelihood of side effects, Ibuxal Plus should be taken with food.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before taking this medicine.
Do not take Ibuxal Plus if you are in the last 3 months of pregnancy, as it may harm your unborn baby or cause problems during delivery. Ibuxal Plus may cause kidney and heart problems in the unborn baby. It may also increase the risk of bleeding in you and your baby and cause delayed or prolonged labor.
In the first 6 months of pregnancy, you should not take Ibuxal Plus unless your doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to become pregnant, you should use the lowest possible dose for the shortest possible time. From the 20th week of pregnancy, Ibuxal Plus may cause kidney problems in the unborn baby if taken for more than a few days. This may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the blood vessel (ductus arteriosus) in the baby's heart. If treatment is required for a longer period, your doctor may recommend additional monitoring.
Ibuxal Plus may make it more difficult to become pregnant. Ibuprofen belongs to a group of medicines that may impair fertility in women. This effect is reversible after stopping the medicine. If you are planning to become pregnant or are having trouble becoming pregnant, you should inform your doctor.
Ibuxal Plus may cause dizziness, drowsiness, fatigue, and vision disturbances in some people. This should be taken into account in situations where full physical and mental fitness is required, e.g., when driving a vehicle. You should exercise caution when driving vehicles and operating machines until you are sure how Ibuxal Plus affects you.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this patient leaflet or as advised by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The medicine is for oral use and should only be used for short-term use.
You should use the smallest effective dose for the shortest duration necessary to relieve the symptoms. If the symptoms of an infection (such as fever and pain) persist or worsen, you should immediately consult a doctor (see section 2).
Ibuxal Plus should not be used for more than 3 days.If the symptoms worsen or do not improve, you should contact your doctor.
Adults:you should take 1 tablet with food or water, up to 3 times a day. You should maintain at least a 6-hour interval between doses.
If the symptoms do not improve after taking one tablet, you can take a maximum of 2 tablets up to 3 times a day. Do not take more than six tablets in 24 hours(which corresponds to 3000 mg of paracetamol, 1200 mg of ibuprofen per day).
Do not use in children under 18 years of age.
If you have taken more than the recommended dose of Ibuxal Plus or if a child has accidentally taken the medicine, you should always consult a doctor or go to the nearest hospital to get an opinion on the possible risk to your health and advice on what actions to take in this situation. Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), gastrointestinal bleeding (see also section 4), diarrhea, headache, ringing in the ears, and nystagmus. You may also experience agitation, drowsiness, disorientation, or coma. Seizures have also been reported. After taking a large dose, there have been reports of drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, feeling cold, and respiratory disorders. Additionally, the prothrombin time/INR may be prolonged, probably due to the disruption of blood clotting factors. Acute kidney failure and liver damage may occur. Exacerbation of asthma is possible in patients with asthma. Additionally, low blood pressure and breathing difficulties may occur.
If you have taken more than the recommended dose of Ibuxal Plus, you should immediately contact your doctor, even if you feel well, as there is a risk of delayed serious liver damage.
You should not take a double dose to make up for a missed dose. If you miss a dose, you should take it as soon as you remember, and the next dose can be taken no earlier than 6 hours later.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data)
Taking such medicines as Ibuxal Plus may be associated with a slightly increased risk of heart attack (myocardial infarction) or stroke (see section 2).
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP.
The expiry date refers to the last day of the month.
There are no special storage instructions for the medicine.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Ibuxal Plus are white to almost white, oval, biconvex, film-coated tablets with dimensions (21 mm x 10.5 mm) ± 0.5 mm, marked with a double circle on one side.
The tablets are packaged in blisters.
A blister pack of white PVC/PVDC/Aluminum foil containing the appropriate number of film-coated tablets or
A child-resistant blister pack of white PVC/PVDC/Aluminum foil containing the appropriate number of film-coated tablets.
Pushing the tablet out of a child-resistant blister pack may require extra effort.
A carton contains 1 blister (10 tablets) or 2 blisters (20 tablets) and a patient leaflet.
Not all pack sizes may be marketed.
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
tel.: +48 61 66 51 500
fax: +48 61 66 51 505
email: biofarm@biofarm.pl
ALKALOID-INT d.o.o.
Šlandrova ulica 4
1231 Ljubljana-Črnuče
Slovenia
Tel.: + 386 1 300 42 90
Fax: + 386 1 300 42 91
email: info@alkaloid.si
or
TERAPIA S.A.
124 Fabricii Street
400 632 Cluj-Napoca
Romania
Tel.: +40 (264) 501 500
Fax: +40 (264) 415 097
email: office@sunpharma.com
Malta
Ibuprofen/Paracetamol Alkaloid-INT 200 mg/500 mg film-coated tablets
Bulgaria
BlokMAX Duo 200 mg/500 mg film-coated tablets
БлокМАКС Дуо 200 mg/500 mg филмирани таблетки
Greece
Ibuprofen/Paracetamol Alkaloid-INT 200 mg/500 mg επικαλυμμένα με
λεπτό υμένιο δισκίο
Hungary
Ibuprofen/Paracetamol Alkaloid-INT 200 mg/500 mg filmtabletta
Poland
Ibuxal Plus
Romania
PADUDEN DUO 200 mg/500 mg comprimate filmate
United Kingdom Ibuprofen/Paracetamol 200 mg/500 mg film-coated tablets
(Northern Ireland)
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.